NASDAQ: IBRX · Biotechnology
Over the past week, ImmunityBio (IBRX) pulled in 18 mentions across Reddit, X and news, and the read is an Adanos Sell. The crowd averages 24% bullish but is sharply divided: News runs 50% bullish while Reddit sits at just 0%. Wall Street is more constructive, with 3 of 3 analysts rating IBRX a buy.
There is little buzz around IBRX this week and little agreement on direction, which is why it reads as a Sell.
Wall Street’s 100% buy share sits next to a crowd that ranges from Reddit at 0% to News at 50%. No other tracker puts the two side by side.
3 analysts have weighed in: a Strong Buy consensus: 3 buy calls against 0 sell, with an average 12-month price target of $13.00.
The Adanos signal blends each source’s bullish ratio, source breadth, buzz intensity and 3-day momentum. This week bullish sits just below the neutral line, momentum is improving and the 3 sources disagree sharply, so the read is a Sell.
Analysts sit 76 points above the crowd average of 24%, the professionals are more constructive than retail. The split is inside the crowd: News reads 50% bullish while Reddit sits at 0%, a 50-point spread that single-source trackers miss.
Over the 30-day window, ImmunityBio (IBRX) buzz held subdued around 22.3 while the price drifted down 19.0% across the period. The chart tracks how social and news attention moved against end-of-day price. Average daily trading volume across the displayed trading days is 10.3M shares. Updated Jul 27, 2026. Over the last 7 trading days, IBRX lost 4.7%. Buzz activity in the recent week averaged 33.4 and was variable, swinging between 21.8 and 60.7. Recent volume is running below the 30-day average, pointing to quieter participation. Daily crowd sentiment leaned bullish on 13 of the 19 days with directional mentions, shown as the green, grey and red breakdown bars below the chart.
Buzz, bullish share, the loudest item and the positive / neutral / negative split for every tracked source over the last 7 days.
No Polymarket data for this stock this week.
Query sentiment for IBRX and 1000+ stocks from your terminal. Filter by source, timeframe and signal strength.
View CLIEmbed live IBRX sentiment on your own site with drop-in web components.
View WidgetsThis week’s sentiment from Adanos, with fundamentals and analyst consensus. A quick-reference snapshot for Jul 27, 2026.
Based on aggregated sentiment from Reddit, X and News sources, ImmunityBio (IBRX) currently carries an Adanos sell signal with 93/100 conviction. The current cross-source average reads 24% bullish across 3 active sources. Those sources contribute 18 tracked mentions over the last 7 days. This is a sentiment-based reading, not financial advice.
Reddit discussion around ImmunityBio (IBRX) is fairly quiet with 3 mentions across 11 tracked subreddits. The tone is 0% bullish with stable 3-day activity momentum, suggesting steady attention.
The crowd reads bearish on ImmunityBio (IBRX), averaging 24% bullish across 3 tracked sources over the last 7 days. The two ends of the range are News at 50% bullish and Reddit at 0%, a 50-point spread. On the professional side, 3 of 3 analysts rate IBRX a buy.
Of the 3 analysts covering ImmunityBio (IBRX), 3 rate it a buy, 0 a hold and 0 a sell, for a strong buy consensus. The average price target is $13.00. That puts the street ahead of the crowd, which averages 24% bullish.
ImmunityBio (IBRX) sentiment is bearish across all 3 tracked sources. X reads 23% bullish, News reads 50% bullish and reddit coverage is the most negative at 0% bullish. The combined signal points to broad sell-side pressure with 93/100 conviction.
Social sentiment data shows consistently bearish discussion around ImmunityBio (IBRX). All 3 tracked sources lean negative, with reddit being the most bearish at 0% bullish. 3-day activity momentum is rising across X. The sell signal carries 93/100 conviction.
X is the dominant discussion channel with 13 mentions (72% of total volume). Reddit contributes 3 mentions and News contributes 2 mentions. Sentiment is bearish across all sources, while x is the only source with rising 3-day activity.
The Adanos signal blends bullish ratio, buzz score, source breadth and 3-day activity momentum into a single buy/sell reading. IBRX's sell signal at 93/100 conviction reflects consistently bearish sentiment across 3 tracked sources. It is a research shortcut, not financial advice.
The IBRX sentiment page is regenerated from the latest 7-day tracking window at each build. Data reflects the most recent Reddit posts, tweets and news articles available in the current publishing cycle.
These stocks share a comparable sentiment profile to ImmunityBio with similar bullish ratios, signal direction and discussion volume. All 6 peers carry sell signals, pointing to broad bearish pressure rather than an IBRX-specific issue.
Every data point on this page comes from the Adanos sentiment APIs. Get a free API key and start querying Reddit, X, News and Polymarket sentiment programmatically.
Get Free API Key